Tissue ablation technologies for localized prostate cancer

Mayo Clinic Proceedings

Volumn 79, Issue 12, 2004, Pages 1547-1555

  Gillett, Michael D ^a   Gettman, Matthew T ^a   Zincke, Horst ^a   Blute, Michael L ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL PAIN; BEAM THERAPY; BRAIN TUMOR; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CAPILLARY LEAK SYNDROME; CATHETER ABLATION; CELL KILLING; CRYOSURGERY; CRYOTHERAPY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; IMPOTENCE; KIDNEY TUMOR; LETHAL DOSE; LIVER TUMOR; MICROWAVE THERAPY; MICTURITION DISORDER; NONSURGICAL INVASIVE THERAPY; PATIENT MONITORING; PERINEUM; POSTOPERATIVE COMPLICATION; PROSTATE CANCER; QUALITY OF LIFE; RADIOISOTOPE THERAPY; RECTUM FISTULA; REVIEW; SALVAGE THERAPY; STRESS INCONTINENCE; TRANSURETHRAL RESECTION; URETHRA FISTULA; URETHRA STENOSIS; URETHRA STRICTURE; URINE INCONTINENCE; URINE RETENTION;

EID: 9644279567     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.12.1547     Document Type: Review

References (47)

1. Walther MC, Shawker TH, Libutti SK, et al. A phase 2 study of radio frequency interstitial tissue ablation of localized renal tumors. J Urol. 2000; 163:1424-1427.
2. Gill IS, Novick AC, Meraney AM, et al. Laparoscopic renal cryoablation in 32 patients. Urology. 2000;56:748-753.
3. Ishida T, Murakami T, Shibata T, et al. Percutaneous microwave tumor coagulation for hepatocellular carcinomas with interruption of segmental hepatic blood flow. J Vasc Interv Radiol. 2002;13(2, pt 1):185-191.
4. Itamoto T, Katayama K, Fukuda S, et al. Percutaneous microwave coagulation therapy for primary or recurrent hepatocellular carcinoma: long-term results. Hepatogastroenterology. 2001;48:1401-1405.
5. Farrell MA, Charboneau WJ, DiMarco DS, et al. Imaging-guided radiofrequency ablation of solid renal tumors. AJK Am J Roentgenol. 2003; 180:1509-1513.
6. Cox RL, Crawford ED. Complications of cryosurgical ablation of the prostate to treat localized adenocarcinoma of the prostate. Urology. 1995; 45:932-935.
7. Porter MP, Ahaghotu CA, Loening SA, See WA. Disease-free and overall survival after cryosurgical monotherapy for clinical stages B and C carcinoma of the prostate: a 20-year followup. J Urol. 1997;158:1466-1469.
8. Pisters LL, Dinney CP, Pettaway CA, et al. A feasibility study of cryotherapy followed by radical prostatectomy for locally advanced prostate cancer. J Urol. 1999;161:509-514.
9. Shinohara K, Connolly JA, Presti JC Jr, Carroll PR. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. J Urol. 1996;156:115-120.
10. Cespedes RD, Pisters LL, von Eschenbach AC, McGuire EJ. Long-term followup of incontinence and obstruction after salvage cryosurgical ablation of the prostate: results in 143 patients. J Urol. 1997;157:237-240.
11. De La Taille A, Benson MC, Bagiella E, et al. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. BJU Int. 2000;85:281-286.
12. Chaussy C, Thuroff S. Results and side effects of high-intensity focused ultrasound in localized prostate cancer. J Endourol. 2001;15:437-440.
13. Zlotta AR, Djavan B, Matos C, et al. Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer. Br J Urol. 1998;81:265-275.
14. Sherar MD, Gertner MR, Yue CK, et al. Interstitial microwave thermal therapy for prostate cancer: method of treatment and results of a phase I/II trial. J Urol. 2001;166:1707-1714.
15. Tucker RD, Huidobro C, Larson T, Platz CE. Use of permanent interstitial temperature self-regulating rods for ablation of prostate cancel. J Endourol. 2000;14:511-517.
16. Gonder MJ, Soanes WA, Shulman S. Cryosurgical treatment of the prostate. Invest Urol. 1966;3:372-378.
17. Cohen JK, Miller RJ, Rooker GM, Shuman BA. Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results. Urology. 1996;47:395-401.
18. Ghafar MA, Johnson CW, De La Taille A, et al. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol. 2001;166:1333-1337.
19. Leibovici D, Zisman A, Siegel YI, Lindner A. Cryosurgical ablation for prostate cancer, preliminary results of a new advanced technique. Isr Med Assoc J. 2001;3:484-487.
20. Zisman A, Pantuck AJ, Cohen JK, Belldegrun AS. Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template-technique and preliminary results. Urology. 2001;58: 988-993.
21. Han KR, Cohen JK, Miller RJ, et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol. 2003;170(4, pt 1):1126-1130.
22. Aus G, Pileblad E, Hugosson J. Cryosurgical ablation of the prostate: 5-year follow-up of a prospective study. Eur Urol. 2002;42:133-138.
23. Donnelly BJ, Saliken JC, Ernst DS, et al. Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology. 2002;60:645-649.
24. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002;60(2, suppl 1):3-11.
25. Amling CL, Blute ML, Bergstralh EJ, Seay TM, Slezak J, Zincke H. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol. 2000;164:101-105.
26. Kupelian PA, Elshaikh M, Reddy CA, Zippe C, Klein EA. Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy. J Clin Oncol. 2002;20:3376-3385.
27. Foster RS, Bihrle R, Sanghvi NT, Fry FJ, Donohue JP. High-intensity focused ultrasound in the treatment of prostatic disease. Eur Urol. 1993; 23(suppl 1):29-33.
28. Madersbacher S, Kratzik C, Susani M, Marberger M. Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound. J Urol. 1994;152(6, pt 1):1956-1960.
29. Madersbacher S, Kratzik C, Marberger M. Prostatic tissue ablation by transrectal high intensity focused ultrasound: histological impact and clinical application. Ultrason Sonochem. 1997;4:175-179.
30. Gelet A, Chapelon JY, Bouvier R, et al. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol. 1996; 29:174-183.
31. Gelet A, Chapelon JY, Bouvier R, Rouviere O, Lyonnet D, Dubernard JM. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome. Eur Urol. 2001;40:124-129.
32. Thuroff S, Chaussy C, Vallancien G, et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol. 2003;17:673-677.
33. Uchida T, Sanghvi NT, Gardner TA, et al. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report. Urology. 2002;59:394-398.
34. Beerlage HP, Thuroff S, Debrayne FM, Chaussy C, de la Rosette JJ. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology. 1999;54:273-277.
35. Kiel HJ, Wieland WF, Rossler W. Local control of prostate cancer by transrectal HIFU-therapy. Arch Ital Urol Androl. 2000;72:313-319.
36. Djavan B, Zlotta AR, Susani M, et al. Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging, with histopathologic examination. Urology. 1997;50:986-992.
37. Leveillee RJ, Hoey MF. Radiofrequency interstitial tissue ablation: wet electrode. J Endourol. 2003;17:563-577.
38. Khair AA, Pacelli A, Iczkowski KA, et al. Does transurethral microwave thermotherapy have a different effect on prostate cancer than on benign or hyperplastic tissue? Urology. 1999;54:67-72.
39. Lancaster C, Toi A, Trachtenberg J. Interstitial microwave thermoablation for localized prostate cancer. Urology. 1999;53:828-831.
40. Algan O, Fosmire H, Hynynen K, et al. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma. Cancer. 2000;89:399-403.
41. Hurwitz MD, Kaplan ID, Svensson GK, Hynynen K, Hansen MS. Feasibility and patient tolerance of a novel transrectal ultrasound hyperthermia system for treatment of prostate cancer. Int J Hyperthermia. 2001;17:31-37.
42. Anscher MS, Samulski TV, Dodge R, Prosnitz LR, Dewhirst MW. Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1997;37:1059-1065.
43. Tucker RD. Use of interstitial temperature self-regulating thermal rods in the treatment of prostate cancer. J Endourol. 2003;17:601-607.
44. Leibovich BC, Blute ML, Bostwick DG, et al. Proximity of prostate cancer to the urethra: implications for minimally invasive ablative therapies. Urology. 2000;56:726-729.
45. Koutcher JA, Zakian K, Hricak H. Magnetic resonance spectroscopic studies of the prostate. Mol Urol. Fall 2000;4:143-152.
46. Kurhanewicz J, Vigneron DB, Males RG, Swanson MG, Yu KK, Hricak H. The prostate: MR imaging and spectroscopy: present and future. Radiol Clin North Am. 2000;38:115-138.
47. Manduca A, Oliphant TE, Dresner MA, et al. Magnetic resonance elastography: non-invasive mapping of tissue elasticity. Med Image Anal. 2001;5:237-254.